Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs. - Wikidata - awgldk - TriplyDB

Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs.

Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs.

http://www.wikidata.org/entity/Q36714535

about

Drug-induced side effects affecting the gastrointestinal tract Inter-relationships between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretion Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis.Why do patients with ulcerative colitis relapse?Selective inhibition of fatty acid oxidation in colonocytes by ibuprofen: a cause of colitis?Platelet activating factor: release from colonic mucosa in patients with ulcerative colitis and its effect on colonic secretion Inflammatory bowel disease and spondylarthropathy.Analgesic ingestion and other factors preceding relapse in ulcerative colitis.Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.Salicylate induced exacerbation of ulcerative colitis.Role of Nonsteroidal Anti-Inflammatory Drugs in Exacerbations of Inflammatory Bowel Disease Colitis caused by non-steroidal anti-inflammatory drugs.Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis.Managing pain in inflammatory bowel disease.Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: pathophysiology and clinical associations.Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease.5-Aminosalicylic acid, a specific drug for ulcerative colitis.Medical treatment of ulcerative colitis.Non-steroidal anti-inflammatory drugs and the lower gastrointestinal tract.Prostaglandins and ulcerative colitis.The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis.Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study.Enteritis and colitis associated with mefenamic acid.Mechanism of action of 5-arninosalicylic acid.Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism Colitis associated with non-steroidal anti-inflammatory drugs.Colitis associated with ibuprofen.Mesalazine induced exacerbation of ulcerative colitis.Mucosal interleukin-6 secretion in ulcerative colitis. Effects of anti-inflammatory drugs and T-cell stimulation.

P2860

Q28219073-07E08B9E-A759-45E8-9FE7-40A9B43AE0D1 Q34377239-25448739-8CA3-4BCC-881D-E1E676C85135 Q34381212-FA0CD548-6E1B-4136-A365-E066B65FFD08 Q34391874-8242AFC9-BB4E-4D71-B4E0-0B82025F91AA Q34407441-B1633EFF-1CCB-4348-BF05-4BB37B01526A Q34409413-E2093D92-C6C2-4C08-80C8-921641D56D64 Q34474693-D45617BD-E8CA-4DFF-AFF6-CC40155F438A Q34495790-6451E069-D4C7-4C56-BEA7-5F91F3279A1B Q34525348-18D27A90-2767-47C4-96D1-647720FBA028 Q34527496-FC0B34D8-B29A-4559-9E8E-CB5903593BA0 Q36437092-8A9A49B6-8A5D-412C-8DB3-52591344B1A7 Q36707405-0B1593C0-EA77-48B6-9AA3-AAA10487C64A Q37085249-E9B99049-D737-4EDD-9AA9-3CB8BFD4B5AF Q37427660-B0B5084E-1B7B-46C3-82BC-B35ADC109619 Q37980743-FD126321-AF01-4E00-B12E-0813F2C17264 Q38250401-865A0869-6996-44EC-8234-AA30AD9D601B Q38260150-20E8464C-8B99-4E52-B920-68B64A6A16A2 Q38367034-7E04FDC3-855A-43C3-A0DE-2E7885C71E27 Q38938913-C8DB5FD8-106A-4428-B25F-0A061870A18C Q39762680-AE28FC82-FBBD-47FC-95CE-C30DD5757401 Q40096108-BBD9ACDF-28C1-49BE-8D70-6843C34E678B Q40443772-226B08DC-A0E2-4229-A514-DDB9F49E92D7 Q41610897-175BC2F5-7441-4198-8DF6-66602D29A5EB Q41939863-FE55AE79-AE25-4B3C-AEEA-D54A6168830D Q42106723-5552C9B0-2691-440B-9AF6-F66BD3074CE2 Q42128208-2993B4E9-1F68-4D3C-9701-9C87630ED564 Q42995358-FFF35D85-D643-47D3-9C6A-1DE7253A527C Q43172864-42B79C80-39A3-416A-AF02-3D711A986E49 Q43225982-FDDFD69B-AE7D-49B9-B77D-60CDBC33D1F7 Q52871467-9FF69A3D-8C42-46FF-B7D7-94FF962F1F6E

P2860

Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs.

http://www.wikidata.org/entity/Q36714535

description

1981 nî lūn-bûn

@nan

1981年の論文

@ja

1981年論文

@yue

1981年論文

@zh-hant

1981年論文

@zh-hk

1981年論文

@zh-mo

1981年論文

@zh-tw

1981年论文

@wuu

1981年论文

@zh

1981年论文

@zh-cn

name

Relapse of ulcerative proctoco ...... oidal anti-inflammatory drugs.

@ast

Relapse of ulcerative proctoco ...... oidal anti-inflammatory drugs.

@en

type

label

Relapse of ulcerative proctoco ...... oidal anti-inflammatory drugs.

@ast

Relapse of ulcerative proctoco ...... oidal anti-inflammatory drugs.

@en

prefLabel

Relapse of ulcerative proctoco ...... oidal anti-inflammatory drugs.

@ast

Relapse of ulcerative proctoco ...... oidal anti-inflammatory drugs.

@en

P1433

Q36714535-3BA1FBAF-A5BF-482E-AE58-57FD4E3DF699

P1476

Q36714535-345580AC-8B08-4F23-B091-918A127CA5A2

P2093

Q36714535-0D63B52A-2873-4D99-BA04-CF866C67D476

Q36714535-33467777-10CC-4285-B904-1706C9CD1AD9

P2860

Q36714535-02B6526C-C9BE-4472-9C91-6A9FEB596469

Q36714535-03892C0E-0BEC-4372-9A4E-6B1B04ABFF3D

Q36714535-4472B89E-D349-4862-87BE-3868B5D7B06C

Q36714535-7EA2D32F-7B37-48BE-B920-D4DD930D1785

Q36714535-C14429B9-A3EE-44BE-BF5A-C177310DA8E3

Q36714535-D1DD28BF-AB3E-4EC5-91DC-ED8EAFF590D2

Q36714535-D891DA13-701D-446C-AAE3-D3BF58DAD684

Q36714535-FB1CBF85-319D-40DE-9DAF-14FA26D6B2FC

P304

Q36714535-79CFB3C4-C72C-4C5A-A215-B85482420372

P31

Q36714535-E39A3063-4863-43AA-A5DF-6AA7BDFB4FDE

P356

Q36714535-2EC69739-7A4E-4B34-8B07-FC9236A7136C

P407

Q36714535-C49D9A8A-990F-421A-9A5D-48C8A5C41ADA

P433

Q36714535-8FFDBEC2-2864-48B9-9FFE-112274C1650E

P478

Q36714535-6D4DFD32-1F92-46F5-8BF5-7C89561DFA80

P577

Q36714535-809AD264-E002-401C-B35A-3483BF372EDB

P5875

Q36714535-3A61B876-A64E-4016-98F3-1D7137747D5B

P698

Q36714535-AAAE2F55-E6C6-4830-9ADB-2350E6D465E0

P921

Q36714535-C5747310-90C7-476C-B8DC-8A5E745F09B2

P932

Q36714535-A0617C3B-9946-421E-995A-6D07271998C3

P356

PGMJ.57.667.297

P1433

Postgraduate Medical Journal

P1476

Relapse of ulcerative proctoco ...... oidal anti-inflammatory drugs.

@en

P2093

Rampton DS

http://www.w3.org/2001/XMLSchema#string

Sladen GE

http://www.w3.org/2001/XMLSchema#string

P2860

Sulphasalazine is a potent inhibitor of prostaglandin 15-hydroxydehydrogenase: possible basis for therapeutic action in ulcerative colitis.

Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.

Cytoprotection by prostaglandins.

Letter: Rectal bleeding and indomethacin suppositories.

Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease.

A comparison of the abilities of acetylsalicylic acid, flurbiprofen and indomethacin to inhibit the release reaction and prostaglandin synthesis in human blood platelets.

Mode of action of aspirin-like drugs.

Acute perforation of colonic diverticula associated with short-term indomethacin.

P304

297-299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/PGMJ.57.667.297

http://www.w3.org/2001/XMLSchema#string

P407

P433

667

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

1981-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

17068158

http://www.w3.org/2001/XMLSchema#string

P698

6117846

http://www.w3.org/2001/XMLSchema#string

P921

P932

2424939

http://www.w3.org/2001/XMLSchema#string